It's a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (the ...

It's a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or 'the Pill') could also help reduce the risk of ovarian cancer, according to ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A mathematical modeling study suggests that ovarian cancer incidence could be reduced and healthcare savings boosted if women who have already completed their families were offered fallopian tube ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In South Africa, the number of cases of ovarian cancer is predicted to rise by a staggering 72.9% by 2050, underscoring the pressing need for greater awareness among women and clinicians ...

While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

BOSTON - Allarity Therapeutics, Inc. (NASDAQ: ALLR), a micro-cap biopharmaceutical company valued at $4.79 million, has announced a new protocol for its ongoing clinical trial of stenoparib, a ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

You can’t pretend the pink pachyderm isn’t staring you in the face on Saturday. But if you must draw attention to it, at least soften the hard edges of your truth with graceful diplomacy. A ...